Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     

MEREO BIOPHARMA GROUP PLC

(MREO)
  Report
Delayed Nasdaq  -  04:00 2022-12-02 pm EST
0.8372 USD   +5.88%
12/02European Equities Move Lower to End Strong Month, Week Lower
MT
12/01European Equities Move Higher Thursday as EU Nears Cap on Russian Oil
MT
11/29Inflation Decline in Germany, Spain Helps Boost European Equities
MT
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisionsFunds 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

Cantor Fitzgerald Starts Mereo BioPharma Group at Overweight With $4 Price Target

08/12/2022 | 08:51am EST


ę MT Newswires 2022
All news about MEREO BIOPHARMA GROUP PLC
12/02European Equities Move Lower to End Strong Month, Week Lower
MT
12/01European Equities Move Higher Thursday as EU Nears Cap on Russian Oil
MT
11/29Inflation Decline in Germany, Spain Helps Boost European Equities
MT
11/28ECB President Lagarde's Comments That Inflation Will Continue to Rise Weigh on European..
MT
11/18Pharmaceutical Stocks Help European Equities Nudge Higher to End Quiet Week
MT
11/15European Markets Move Higher Helped by Upbeat US Inflation Data
MT
11/10SVB Securities Trims Price Target on Mereo BioPharma Group to $4 From $8, Maintains Out..
MT
11/08European ADRs Move Higher in Tuesday Trading, Adding to Monday's Gains
MT
11/08Mereo BioPharma to Participate in Fireside Chat at the Jefferies London Healthcare Conf..
AQ
11/07European ADRs Rise in Monday Trading
MT
More news
Analyst Recommendations on MEREO BIOPHARMA GROUP PLC
More recommendations
Financials
Sales 2022 - - -
Net income 2022 -9,99 M -12,2 M -12,2 M
Net cash 2022 41,6 M 51,0 M 51,0 M
P/E ratio 2022 -22,8x
Yield 2022 -
Capitalization 74,3 M 91,0 M 91,0 M
EV / Sales 2022 -
EV / Sales 2023 4,20x
Nbr of Employees 49
Free-Float 51,6%
Chart MEREO BIOPHARMA GROUP PLC
Duration : Period :
Mereo BioPharma Group plc Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends MEREO BIOPHARMA GROUP PLC
Short TermMid-TermLong Term
TrendsNeutralNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 4
Last Close Price 68,35 GBX
Average target price 370,20 GBX
Spread / Average Target 442%
EPS Revisions
Managers and Directors
Denise Vera Scots-Knight Chief Executive Officer & Director
Christine Fox Chief Financial Officer
Michael S. Wyzga Chairman
John A. Lewicki Chief Scientific Officer
Suba Krishnan Senior Vice President-Clinical Development
Sector and Competitors
1st jan.Capi. (M$)
MEREO BIOPHARMA GROUP PLC-47.68%91
VERTEX PHARMACEUTICALS46.34%82 493
REGENERON PHARMACEUTICALS, INC.20.54%81 852
BIONTECH SE-34.16%41 250
WUXI APPTEC CO., LTD.-34.47%32 173
GENMAB A/S24.60%30 178